SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001493152-23-038632
Filing Date
2023-10-30
Accepted
2023-10-30 09:31:15
Documents
1
Period of Report
2023-06-30
Effectiveness Date
2023-10-30

Document Format Files

Seq Description Document Type Size
1 formars.pdf ARS 883819
  Complete submission text file 0001493152-23-038632.txt   1218607
Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: ARS | Act: 34 | File No.: 001-40388 | Film No.: 231357768
SIC: 2834 Pharmaceutical Preparations